Galderma Group AG (GALDY)
Galderma Group Market Cap: 48.99B for Dec. 24, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BeOne Medicines Ltd. | 34.49B |
| AC Immune SA | 310.85M |
| CRISPR Therapeutics AG | 5.403B |
| Addex Therapeutics Ltd. | 9.511M |
| NewCelX Ltd. | 1.181M |
Market Cap Related Metrics
| PE Ratio | 130.43 |
| PS Ratio | 10.59 |
| Price to Free Cash Flow | 67.29 |
| Price | 41.72 |
| Earnings Yield | 0.77% |
| Operating PE Ratio | 67.99 |
| Normalized PE Ratio | 117.97 |